What is the FlowTriever®?
The FlowTriever® is the first mechanical thrombectomy device FDA indicated and purposebuilt for treatment of pulmonary embolism, removing large clots from large vessels, immediately restoring blood flow, and relieving right heart strain without the need for thrombolytic drugs or ICU stay.

Highlights & Clinical Benefits:

• Immediate symptom improvement
• Single session treatment
• Eliminates the need for thrombolytics and ICU stay
• Minimizes blood loss
• Avoids Capital Equipment

Which patients are best for FlowTriever®?

Acute PE patients with significant clot burden in segmental or central pulmonary arteries. Further considerations should be made for patients with significant right heart dysfunction defined as: RV/LV >0.9, RV Hypokinesis on ECHO, or elevated cardiac biomarkers.